Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.
2.
3.
4.
5.
6.

Disease-branding and drug-mongering: could pharmaceutical industry promotional practices result in tort liability?

Cetel JS.

Seton Hall Law Rev. 2012;42(2):643-702. No abstract available.

PMID:
22708139
7.

Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.

Poser S.

Food Drug Law J. 2007;62(4):653-94. No abstract available.

PMID:
18557225
8.

Direct-to-consumer advertising and shared liability for pharmaceutical manufacturers.

Mello MM, Rosenthal M, Neumann PJ.

JAMA. 2003 Jan 22-29;289(4):477-81. No abstract available.

PMID:
12533128
9.

A defense of the learned intermediary doctrine.

Goetz RB, Growdon KR.

Food Drug Law J. 2008;63(2):421-38. No abstract available.

PMID:
18561470
10.

Products liability: the fate of the learned intermediary doctrine.

Wong A.

J Law Med Ethics. 2002 Fall;30(3):471-4. No abstract available.

PMID:
12497713
11.

The federal preemption debate in pharmaceutical labeling product liability actions.

Gross JM, Curry JA.

Tort Trial Insur Pract Law J. 2007 Fall;43(1):35-70. No abstract available.

PMID:
18354866
12.

Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.

Reichertz PS.

Food Drug Law J. 1996;51(3):355-65. No abstract available.

PMID:
11797712
13.

The duty of the pharmacist and the pharmaceutical industry.

Dwyer P.

Med Law. 2003;22(3):495-516. Review.

PMID:
14626883
14.

To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.

Schwartz MI.

Food Drug Law J. 2008;63(1):1-33. No abstract available.

PMID:
18561453
15.
16.

The impact of Wyeth v. Levine on FDA regulation of prescription drugs.

Ausness RC.

Food Drug Law J. 2010;65(2):247-83, i-ii.

PMID:
24475542
18.

The courts should not apply the seriously flawed learned intermediary doctrine.

Gale A.

Mo Med. 2015 Jan-Feb;112(1):29. No abstract available.

PMID:
25812270
19.

How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.

Mintzes B, Barer ML, Kravitz RL, Bassett K, Lexchin J, Kazanjian A, Evans RG, Pan R, Marion SA.

CMAJ. 2003 Sep 2;169(5):405-12.

Supplemental Content

Support Center